Venus Concept Inc. (VERO)
0.34
-0.02 (-5.56%)
At close: Jan 14, 2025, 3:59 PM
0.35
3.03%
After-hours Jan 14, 2025, 05:50 PM EST
undefined% (undefined)
| Bid | 0.33 |
| Market Cap | 2.47M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -7.97 |
| PE Ratio (ttm) | -0.04 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 0.4 |
| Volume | 256,618 |
| Avg. Volume (20D) | 985,093 |
| Open | 0.37 |
| Previous Close | 0.36 |
| Day's Range | 0.33 - 0.40 |
| 52-Week Range | 0.28 - 2.21 |
| Beta | undefined |
About VERO
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application devi...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 12, 2017
Employees 304
Stock Exchange NASDAQ
Ticker Symbol VERO
Website https://www.venusconcept.com
Analyst Forecast
According to 1 analyst ratings, the average rating for VERO stock is "Hold." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 0.00%
Hold 100.00%
Sell 0.00%
2 months ago ·
Source
-10.02%
Venus Concept shares are trading higher. The compa...
Unlock content with
Pro Subscription
3 months ago ·
Source
+20.97%
Venus Concept shares are trading higher after the company announced a $15 million debt-to-equity exchange transaction.
